- Ghana has been earmarked as one of the 145 counties of the UN-led COVAX Facility, to take delivery of 2.4 million doses of the AstraZeneca vaccine
- The facility announced that delivery is estimated to be made before the end of February
- The vaccine is expected to be administered to people in key sectors such as health workers in the first quarter
Our manifesto: This is what YEN.com.gh believes in
With the scary surge in cases of the coronavirus related cases, it is quite refreshing to know that very soon vaccines to prevent infections would be made available.
The COVID-19 vaccine has been rumoured to be one of the effective things that will help control the spread of the virus.
President Akufo-Addo in his 23rd address to the nation on COVID-19 measures taken to curb the virus spread mentioned that vaccines would soon be procured and brought down to Ghana.
He announced that steps were taken to secure a vaccine to help prevent the spread.
In his address, he said the first batch of the over 17 million vaccines the country is expecting would be arriving in March 2021.
However, the latest update indicates that Ghana has been earmarked as one of the 145 counties of the UN-led COVAX Facility, to take delivery of 2.4 million doses of the AstraZeneca vaccine which is licensed to the Serum Institute of India (AZ/SII).
On Wednesday, February 3, the facility announced that the delivery is estimated to begin before the end of February.
The vaccine is expected to be administered to persons in key sectors such as health workers in the first quarter.
Haruna Iddrisu, the leader of the minority group in Parliament urged President Nana Akufo-Addo to expedite moves to procure the COVID-19 vaccines.
Ghana is set to procure her first consignment of the COVID vaccines within the first half of this year, President Akufo-Addo stated.
Since then, a lot of work is ongoing towards the realisation of this. The administration aims to vaccinate the entire population, with an initial target of twenty million people.
Meanwhile, a freshly published study has revealed that even after receiving the first or second dose of COVID-19 vaccines, a cross-section of recipients still test positive for the virus.
The research conducted by CDC observed post-vaccination COVID-19 among healthcare workers in Israel.
Enjoy reading our stories? Join YEN.com.gh's Telegram channel!